Literature DB >> 11886997

Color Doppler ultrasound for monitoring free flaps in the head and neck region.

Laszlo Seres1, Eva Makula, Zita Morvay, Laszlo Borbely.   

Abstract

The use of microvascular free flaps has become established as a very reliable reconstructive technique following tumor surgery or trauma in the head and neck region. Occasionally, flap compromise may occur which will require immediate re-exploration. Early diagnosis of vascular insufficiency is essential. Clinical signs are not always reliable. Numerous systems have been described for monitoring the viability of microsurgical free flaps. The authors consider that color Doppler ultrasound is one of the most useful diagnostic tools. Three cases are reviewed in which this technique aided the decision whether re-exploration was necessary.

Entities:  

Mesh:

Year:  2002        PMID: 11886997     DOI: 10.1097/00001665-200201000-00016

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  3 in total

1.  [Intra- and postoperative monitoring of transplanted flaps. Measurement of the partial pressure of oxygen in tissue].

Authors:  O Driemel; I Oberfahrenhorst; S G Hakim; H Kosmehl; H Pistner
Journal:  Mund Kiefer Gesichtschir       Date:  2004-09-18

2.  Head and neck reconstruction with free flaps: a report on 213 cases.

Authors:  Olivier Dassonville; Gilles Poissonnet; Emmanuel Chamorey; Jacques Vallicioni; François Demard; Joseph Santini; Mayeul Lecoq; Sophie Converset; Pouya Mahdyoun; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-08-10       Impact factor: 2.503

3.  Early risk prognosis of free-flap transplant failure by quantitation of the macrophage colony-stimulating factor in patient plasma using 2-dimensional liquid-chromatography multiple reaction monitoring-mass spectrometry.

Authors:  Jingzhi Yang; Juliane C Finke; Juncong Yang; Andrew J Percy; Uwe von Fritschen; Christoph H Borchers; Michael O Glocker
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.